Similar articles

• Heterogeneity of posterior limbic perfusion in very early Alzheimer's disease.

  Nagao M, Sugawara Y, Ikeda M, Fukuhara R, Ishikawa T, Murase K, Kikuchi T, Mochizuki T, Miki H. Nagao M, et al. Neurosci Res. 2006 Jul;55(3):285-91. doi: 10.1016/j.neures.2006.03.006. Epub 2006 Apr 27. Neurosci Res. 2006. PMID: 16644047
• Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET.

  Callen DJ, Black SE, Caldwell CB. Callen DJ, et al. Eur J Nucl Med Mol Imaging. 2002 Jul;29(7):899-906. doi: 10.1007/s00259-002-0816-3. Epub 2002 Apr 27. Eur J Nucl Med Mol Imaging. 2002. PMID: 12111130 Clinical Trial.
• Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.

  Sánchez SM, Abulafia C, Duarte-Abritta B, de Guevara MSL, Castro MN, Drucaroff L, Sevlever G, Nemeroff CB, Vigo DE, Loewenstein DA, Villarreal MF, Guinjoan SM. Sánchez SM, et al. J Alzheimers Dis. 2017;60(3):1183-1193. doi: 10.3233/JAD-170491. J Alzheimers Dis. 2017. PMID: 28984601 Free PMC article.
• GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.

  Lanctôt KL, Herrmann N, Mazzotta P, Khan LR, Ingber N. Lanctôt KL, et al. Can J Psychiatry. 2004 Jul;49(7):439-53. doi: 10.1177/070674370404900705. Can J Psychiatry. 2004. PMID: 15362248 Review.
• Correlative studies in Alzheimer's disease.

  Merskey H, Blume WT, Colhoun EH, Fisman M, Fox AJ, Fox H, Hachinski VC, Kral VA, Rylett RJ, Smith R. Merskey H, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):509-14. doi: 10.1016/0278-5846(85)90010-7. Prog Neuropsychopharmacol Biol Psychiatry. 1985. PMID: 3911282 Review.